跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DIFFLAM ANTI-INFLAMMATORY GEL benzydamine hydrochloride 30mg/g gel tube - TGA Drug Approval Details
Approvals
/
TGA
/
DIFFLAM ANTI-INFLAMMATORY GEL benzydamine hydrochloride 30mg/g gel tube
Approved
STANDARD
DIFFLAM ANTI-INFLAMMATORY GEL benzydamine hydrochloride 30mg/g gel tube
iNova Pharmaceuticals (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
19187d1e4ea12492
Company
iNova Pharmaceuticals (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
19187d1e4ea12492
Product Name
DIFFLAM ANTI-INFLAMMATORY GEL benzydamine hydrochloride 30mg/g gel tube
Artg Id
10930
Artg Name
DIFFLAM ANTI-INFLAMMATORY GEL benzydamine hydrochloride 30mg/g gel tube
Sponsor
iNova Pharmaceuticals (Australia) Pty Ltd
Company Detail Path
/organization/inova-pharmaceuticals-australia-pty-limited
Artg Date
1991-07-16
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
19187d1e4ea12492
Type
Standard
Back to TGA Approvals
